Techniques, Timing, and Prognosis of Transcatheter Post Myocardial Infarction Ventricular Septal Defect Repair.


Journal

Current cardiology reports
ISSN: 1534-3170
Titre abrégé: Curr Cardiol Rep
Pays: United States
ID NLM: 100888969

Informations de publication

Date de publication:
20 05 2019
Historique:
entrez: 22 5 2019
pubmed: 22 5 2019
medline: 23 2 2020
Statut: epublish

Résumé

This review aims to delineate the actual role of percutaneous intervention in the closure of post-myocardial infarction ventricular septal defect (post-MI VSD) and to briefly summarize the main steps of this procedure. Most of the published studies report experiences using Amplatzer devices for post-MI VSD closure. In the acute phase, morbidity and mortality are quite high up to 70%, with a mean success rate of 90%, with 95% confidence intervals from 60 to 100%, and a 30-day mortality of 40%, with 95% confidence intervals from 0 to 55%. In the chronic phase, that is 14 days after myocardial infarction, results are very encouraging, with lower morbidity and mortality (23% at 30 days) and a higher rate of complete closure. A multimodality imaging approach has been proposed in order to increase the success rate of this procedure. Percutaneous closure is a safe and effective procedure in highly specialized centers and an appropriate patient selection is of paramount importance to the success of the procedure. Device closure of post-MI VSD can be considered a true alternative to the standard surgical approach. However, many problems still exist for percutaneous post-MI VSD treatment.

Identifiants

pubmed: 31111245
doi: 10.1007/s11886-019-1142-8
pii: 10.1007/s11886-019-1142-8
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

59

Références

Eur Heart J. 2009 Jan;30(1):81-8
pubmed: 19036747
Eur Heart J. 2018 Jan 7;39(2):119-177
pubmed: 28886621
Indian Heart J. 2016 Sep;68 Suppl 2:S60-S63
pubmed: 27751330
Indian Heart J. 2016 Jan-Feb;68(1):99-101
pubmed: 26896275
Ann Thorac Surg. 2009 May;87(5):1421-5
pubmed: 19379878
Catheter Cardiovasc Interv. 2007 Feb 15;69(3):403-7
pubmed: 17195200
Catheter Cardiovasc Interv. 2015 Dec 1;86(7):1264-70
pubmed: 26033272
Cardiovasc Diagn Ther. 2016 Apr;6(2):180-4
pubmed: 27054108
Cardiovasc Surg. 2003 Apr;11(2):149-54
pubmed: 12664051
CASE (Phila). 2017 Aug 18;1(5):207-209
pubmed: 30062282
Circulation. 2000 Jan 4-11;101(1):27-32
pubmed: 10618300
J Invasive Cardiol. 2002 Jun;14(6):322-7
pubmed: 12042624
JACC Cardiovasc Interv. 2017 Jun 26;10(12):1233-1243
pubmed: 28641844
J Interv Cardiol. 2018 Dec;31(6):939-948
pubmed: 30318677
J Am Coll Cardiol. 2000 Sep;36(3 Suppl A):1110-6
pubmed: 10985713
Braz J Cardiovasc Surg. 2017 May-Jun;32(3):147-155
pubmed: 28832791
Ann Thorac Surg. 2012 Aug;94(2):436-43; discussion 443-4
pubmed: 22626761
Ann Saudi Med. 2014 Mar-Apr;34(2):171-4
pubmed: 24894788
Cardiovasc Revasc Med. 2018 Nov 20;:
pubmed: 30527592
Eur J Cardiothorac Surg. 2003 Dec;24(6):940-6
pubmed: 14643812
Interact Cardiovasc Thorac Surg. 2009 Nov;9(5):879-87
pubmed: 19692439
Catheter Cardiovasc Interv. 2016 Apr;87(5):926-30
pubmed: 26757420
Circulation. 1988 Aug;78(2):361-8
pubmed: 3396173
Catheter Cardiovasc Interv. 2004 Feb;61(2):196-201
pubmed: 14755811
Heart Lung Circ. 2016 Nov;25(11):1063-1066
pubmed: 27374861
Heart Lung Circ. 2008 Apr;17(2):119-23
pubmed: 18060839
Catheter Cardiovasc Interv. 2012 Sep 1;80(3):485-92
pubmed: 22511555
Catheter Cardiovasc Interv. 2003 Jun;59(2):238-43
pubmed: 12772250
EuroIntervention. 2016 May 17;12(1):94-102
pubmed: 27173869
Rev Esp Cardiol. 2007 May;60(5):548-51
pubmed: 17535768
Eur J Cardiothorac Surg. 2003 Mar;23(3):323-7
pubmed: 12614801
Indian Heart J. 2018 Jul - Aug;70(4):519-527
pubmed: 30170647
Eur J Cardiothorac Surg. 2002 Apr;21(4):725-31; discussion 731-2
pubmed: 11932175
J Interv Cardiol. 2017 Feb;30(1):63-71
pubmed: 28078714
J Cardiovasc Thorac Res. 2015;7(2):75-7
pubmed: 26191397
JACC Cardiovasc Interv. 2016 Nov 14;9(21):2259-2261
pubmed: 27832852

Auteurs

Alessia Faccini (A)

Department of Congenital Cardiology and Cardiac Surgery, IRCCS Policlinico San Donato, San Donato Milanese, Italy.

Gianfranco Butera (G)

Department of Pediatric Cardiology and Adults with Congenital Heart Disease, Evelina Children's Hospital- St Thomas Hospital, 249 Westminster Bridge Road, London, SE1 7EH, UK. gianfrancobutera@libero.it.
King's College London, 57 Waterloo Road, London, SE1 8WA, UK. gianfrancobutera@libero.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH